Multinationals on China｜Anna Van Acker: We will continue to bring more innovative drugs to China

南方财经全媒体记者 施诗 上海报道

During an interview with SFC, Anna Van Acker, President of MSD in China and Senior Vice-President of MSD, reaffirmed MSD’s continuous investment and support for Healthy China 2030.

MSD has been developing in China for more than 30 years. Acker highlighted three engines of MSD’s development in China which are around R&D, manufacturing and commercial operations. She emphasized that MSD will continue to invest in public health, and to tackle the huge unmet medical needs in China.

策划：于晓娜  

监制：施诗

责任编辑：和佳

记者：施诗 杨雨莱

剪辑：李群

设计：林军明

新媒体统筹：丁青云 曾婷芳 赖禧 黄达迅

海外运营监制: 黄燕淑

海外运营内容统筹: 黄子豪

海外运营编辑：庄欢 吴婉婕 龙李华 张伟韬

出品：南方财经全媒体集团